Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Report
  • Published:

p38α MAPK is required for contact inhibition


Proliferation of nontransformed cells is regulated by cell–cell contacts, which are referred to as contact-inhibition. Despite its generally accepted importance for cell cycle control, knowledge about the intracellular signalling pathways involved in contact inhibition is scarce. In the present work we show that p38α mitogen-activated protein kinase (MAPK) is involved in the growth-inhibitory signalling cascade of contact inhibition in fibroblasts. p38α activity is increased in confluent cultures of human fibroblasts compared to proliferating cultures. Time course studies show a sustained activation of p38α in response to cell–cell contacts in contrast to a transient activation after serum stimulation. The induction of contact inhibition by addition of glutaraldehyde-fixed cells is impaired by pharmacological inhibition of p38 as well as in p38α−/− fibroblasts. Further evidence for a central role of p38α in contact inhibition comes from the observation that p38α−/− fibroblasts show a higher saturation density compared to wild-type (wt) fibroblasts, which is reversed by reconstituted expression of p38α. In agreement with a defect in contact inhibition, p27Kip1 accumulation is impaired in p38α−/− fibroblasts compared to wt fibroblasts. Hence, our work shows a new role for p38α in contact inhibition and provides a mechanistic basis for the recently proposed tumour suppressive function of this MAPK pathway.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others


  • Abercrombie M . (1979). Nature, 281, 259–262.

  • Ambrosino C and Nebreda AR . (2001). Biol. Cell, 93, 47–51.

  • Bulavin DV, Demidov O, Saito S, Kauraniemi P, Phillips C, Amundson S, Ambrosino C, Sauter G, Nebreda A, Anderson C, Kallioniemi A, Fornace Jr A and Appella E . (2002). Nat. Genet., 31, 210–215.

  • Bulavin DV, Phillips C, Nannenga B, Timofeev O, Donehower LA, Anderson CW, Appella E and Fornace Jr AJ . (2004). Nat. Genet., 36, 343–350.

  • Casanovas O, Miro F, Estanyol JM, Itarte E, Agel N and Bachs O . (2000). J. Biol. Chem., 275, 35091–35097.

  • Cohen P . (1997). Trends Cell Biol., 7, 353–361.

  • Conrad PW, Rust RT, Han J, Millhorn DE and Beitner-Johnson D . (1999). J. Biol. Chem., 274, 23570–23576.

  • Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher T, Young P and Lee JC . (1995). FEBS Lett., 364, 229–233.

  • Dietrich C, Bartsch T, Schanz F, Oesch F and Wieser R . (1996). Proc. Natl. Acad. Sci. USA, 93, 10815–10819.

  • Dietrich C, Wallenfang K, Oesch F and Wieser F . (1997). Oncogene, 15, 2743–2747.

  • Dulic V, Lees E and Reed SI . (1992). Science, 257, 1958–1961.

  • Eagle H and Levine E . (1967). Nature, 213, 1102–1106.

  • Ellinger-Ziegelbauer H, Kelly K and Siebenlist U . (1999). Mol. Cell. Biol., 19, 3857–3868.

  • Gradl G, Faust D, Oesch F and Wieser R . (1995). Curr. Biol., 5, 526–535.

  • Haq R, Brenton JD, Takahashi M, Finan D, Rottapel R and Zanke B . (2002). Cancer Res., 62, 5076–5082.

  • Heit I, Wieser R, Herget T, Faust D, Borchert-Stuhlträger M, Oesch F and Dietrich C . (2001). Oncogene, 20, 5143–5154.

  • Laemmli UK . (1970). Nature, 227, 680–685.

  • Lavoie JN, L’Allemain G, Brunet A, Müller R and Poussegur J . (1996). J. Biol. Chem., 271, 20608–20616.

  • Molnar A, Theodoras AM, Zon LI and Kyriakis JM . (1997). J. Biol. Chem., 272, 13229–13235.

  • Nakatsuji Y and Miller RH . (1998). Glia, 22, 379–389.

  • Nebreda AR and Porras A . (2000). Trends Biochem. Sci., 25, 257–260.

  • Oesch F, Janik-Schmitt B, Ludewig G, Glatt H-R and Wieser R . (1987). Eur. J. Cell Biol., 43, 403–407.

  • Ono K and Han J . (2000). Cell. Signal., 12, 1–13.

  • Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM and Koff A . (1994). Genes Dev., 8, 9–22.

  • Shi Y and Gaestel M . (2002). Biol. Chem., 383, 1519–1536.

  • Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ and Klenk DC . (1985). Anal. Biochem., 150, 76–85.

  • Wang XZ and Ron D . (1996). Science, 272, 1347–1349.

  • Wang W, Chen JX, Liao R, Deng Q, Zhou JJ, Huang S and Sun P . (2002). Mol. Cell. Biol., 22, 3389–3403.

  • Wieser R, Heck R and Oesch F . (1985). Exp. Cell Res., 158, 493–499.

  • Wieser R and Oesch F . (1986). J. Cell Biol., 103, 361–367.

  • Wieser R, Schütz S, Tschank G, Dienes H-P, Thomas H and Oesch F . (1990). J. Cell Biol., 111, 2681–2692.

  • Wieser R, Baumann C and Oesch F . (1995). Glycoconjugate J., 12, 672–679.

  • Wieser R, Faust D, Dietrich C and Oesch F . (1999). Oncogene, 18, 277–281.

Download references


The expert technical assistance of Sandra Niemann and Emma Black is gratefully acknowledged. This work was supported by the Grant Di 793/1-2 by the Deutsche Forschungsgemeinschaft (CD), by a grant by the Stiftung Rheinland-Pfalz für Innovation (8312-386261/539) and by a grant of the Fundacion Cientifica de la Asociacion Española Contra el Cancer (ARN).

Author information

Authors and Affiliations


Corresponding author

Correspondence to Cornelia Dietrich.

Additional information

Supplementary Information accompanies the paper on Oncogene website (

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Faust, D., Dolado, I., Cuadrado, A. et al. p38α MAPK is required for contact inhibition. Oncogene 24, 7941–7945 (2005).

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI:


This article is cited by


Quick links